THE global leader in  blood management solutions for our customers

RSS Content

Haemonetics Sets Date for Publishing 4th Quarter and Full Fiscal Year 2017 Results and for Providing Fiscal 2018 Guidance: May 8, 2017

BRAINTREE, Mass., April 26, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company will publish fourth quarter and full fiscal year 2017 financial results, and will provide guidance for fiscal year 2018, at 6:00am Eastern Time on Monday, May 8, 2017. The Company will hold a webcast conference call with investors and analysts to discuss results and guidance and to answer questions, at 8:00am Eastern Time on May 8, 2017. 

Webcast Link:  

Webcast replay will be available from May 8, 2017 after 10:00am Eastern Time.


Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit  

Gerry Gould, VP-Investor Relations
(781) 356-9402

To view the original version on PR Newswire, visit:

SOURCE Haemonetics Corporation